Sixteen new lung function signals identified through 1000 Genomes Project reference panel imputation

Nature Communications

Volumn 6, Issue , 2015, Pages

  Artigas, María Soler ^a   Wain, Louise V ^a   Miller, Suzanne ^b   Kheirallah, Abdul Kader ^b   Huffman, Jennifer E ^c   Ntalla, Ioanna ^a   Shrine, Nick ^a   Obeidat, Ma'en ^d   Trochet, Holly ^c,e   McArdle, Wendy L ^f   Alves, Alexessander Couto ^g   Hui, Jennie ^h,i,j   Zhao, Jing Hua ^k   Joshi, Peter K ^l   Teumer, Alexander ^m   Albrecht, Eva ⁿ   Imboden, Medea ^o,p   Rawal, Rajesh ^n,o   Lopez, Lorna M ^q   Marten, Jonathan ^c   Enroth, Stefan ^r   Surakka, Ida ^s,t   Polasek, Ozren ^l,u   Lyytikäinen, Leo Pekka ^v,w   Granell, Raquel ^f   Hysi, Pirro G ^x   Flexeder, Claudia ⁿ   Mahajan, Anubha ^y   Beilby, John ^h,i,j   Bossé, Yohan ^z   Brandsma, Corry Anke ^aa   Campbell, Harry ^l   Gieger, Christian ⁿ   Gläser, Sven ^m   González, Juan R ^ab,ac,ad   Grallert, Harald ⁿ   Hammond, Chris J ^x   Harris, Sarah E ^q   Hartikainen, Anna Liisa ^ae   Heliövaara, Markku ^t   Henderson, John ^f   Hocking, Lynne ^e,af   Horikoshi, Momoko ^y,ag   Hutri Kähönen, Nina ^w,ah   Ingelsson, Erik ^y,ai,aj   Johansson, Åsa ^r,ai   Kemp, John P ^f,ak,al   Kolcic, Ivana ^u   Kumar, Ashish ^o,p,y,am   Lind, Lars ^ai   Melén, Erik ^an   Musk, Arthur W ^h,i,ao   Navarro, Pau ^c   Nickle, David C ^ap   Padmanabhan, Sandosh ^e,aq   Raitakari, Olli T ^ar,as   Ried, Janina S ⁿ   Ripatti, Samuli ^s,at   Schulz, Holger ^n,au   Scott, Robert A ^k   Sin, Don D ^d   Starr, John M ^q   Viñuela, Ana ^x   Völzke, Henry ^m   Wild, Sarah H ^l   Wright, Alan F ^c   Zemunik, Tatijana ^u   Jarvis, Deborah L ^g   Spector, Tim D ^x   Evans, David M ^f,ak,al   Lehtimäki, Terho ^v,w   Vitart, Veronique ^c   Kähönen, Mika ^w   Gyllensten, Ulf ^r   Rudan, Igor ^l   Deary, Ian J ^q   Karrasch, Stefan ^n,av,aw   Probst Hensch, Nicole M ^o,p   Heinrich, Joachim ^n,au,aw   Stubbe, Beate ^m   Wilson, James F ^c,l   Wareham, Nicholas J ^k   James, Alan L ^h,i,ao   Morris, Andrew P ^y,ax,ay   Jarvelin, Marjo Riitta ^g,ae,az,ba   Hayward, Caroline ^e   Sayers, Ian ^b   Strachan, David P ^bb   Hall, Ian P ^b   Tobin, Martin D ^a,bc   Deloukas, Panos ^bd   Hansell, Anna L ^g   Hubbard, Richard ^be   Jackson, Victoria E ^a   Marchini, Jonathan ^bf   Pavord, Ian ^bf   Thomson, Neil C ^bg   Zeggini, Eleftheria ^at   more..

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^e NHS GREATER GLASGOW AND CLYDE   (United Kingdom)

^f UNIVERSITY OF BRISTOL   (United Kingdom)

^g IMPERIAL COLLEGE LONDON   (United Kingdom)

^h Busselton Population Medical Research Foundation   (Australia)

ⁱ SIR CHARLES GAIRDNER HOSPITAL   (Australia)

^j UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^k UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^l UNIVERSITY OF EDINBURGH   (United Kingdom)

^m UNIVERSITY MEDICINE GREIFSWALD   (Germany)

ⁿ INSTITUTE OF EPIDEMIOLOGY   (Germany)

^o SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

^p UNIVERSITY OF BASEL   (Switzerland)

^q UNIVERSITY OF EDINBURGH   (United Kingdom)

^r UPPSALA UNIVERSITY   (Sweden)

^s UNIVERSITY OF HELSINKI   (Finland)

^t NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^u UNIVERSITY OF SPLIT   (Croatia)

^v FIMLAB LABORATORIES   (Finland)

^w TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^x KING'S COLLEGE LONDON   (United Kingdom)

^y UNIVERSITY OF OXFORD   (United Kingdom)

^z LAVAL UNIVERSITY   (Canada)

^aa UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^ab CENTRE FOR RESEARCH IN ENVIRONMENTAL EPIDEMIOLOGY CREAL   (Spain)

^ac CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^ad UNIVERSITAT POMPEU FABRA   (Spain)

^ae OULU UNIVERSITY HOSPITAL   (Finland)

^af UNIVERSITY OF ABERDEEN   (United Kingdom)

^ag UNIVERSITY OF OXFORD   (United Kingdom)

^ah TAMPERE UNIVERSITY HOSPITAL   (Finland)

^ai UPPSALA UNIVERSITY   (Sweden)

^aj STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^ak UNIVERSITY OF QUEENSLAND   (Australia)

^al UNIVERSITY OF BRISTOL   (United Kingdom)

^am KAROLINSKA INSTITUTE   (Sweden)

^an SACHS CHILDREN S HOSPITAL   (Sweden)

^ao UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^ap MERCK RESEARCH LABORATORIES   (United States)

^aq UNIVERSITY OF GLASGOW   (United Kingdom)

^ar TURKU UNIVERSITY HOSPITAL   (Finland)

^as UNIVERSITY OF TURKU   (Finland)

^at WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^au German Center for Lung Research (DZL)   (Germany)

^av TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^aw LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^ax UNIVERSITY OF LIVERPOOL   (United Kingdom)

^ay UNIVERSITY OF TARTU   (Estonia)

^az UNIVERSITY OF OULU   (Finland)

^ba UNIVERSITY OF OULU   (Finland)

^bb ST GEORGE S HOSPITAL   (United Kingdom)

^bc GLENFIELD HOSPITAL   (United Kingdom)

^bd QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^be UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^bf UNIVERSITY OF OXFORD   (United Kingdom)

^bg UNIVERSITY OF GLASGOW   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

DISEASE INCIDENCE; GENETIC ANALYSIS; GENETIC MARKER; GENOME; HISTOPATHOLOGY; POLYMORPHISM;

ADULT; AK097794 GENE; ANCESTRY GROUP; AP1S2 GENE; ARTICLE; ASTN2 GENE; CCDC91 GENE; CHILD; CONTROLLED STUDY; ENSA GENE; EUROPE; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; GENE; GENE FREQUENCY; GENE FUNCTION; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOME ANALYSIS; GENOTYPE; GPR126 GENE; HUMAN; HUMAN GENOME PROJECT; KCNS3 GENE; LHX3 GENE; LTBP4 GENE; MAJOR CLINICAL STUDY; MALE; META ANALYSIS (TOPIC); MN1 GENE; NPNT GENE; QUANTITATIVE TRAIT LOCUS; RIN3 GENE; RNU5F 1 GENE; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; TBX3 GENE; TEKT5 GENE; TRIP11 GENE; AGED; CAUCASIAN; GENETICS; GENOME-WIDE ASSOCIATION STUDY; LUNG; LUNG DISEASE; MIDDLE AGED; PATHOPHYSIOLOGY; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FORCED EXPIRATORY VOLUME; GENOME-WIDE ASSOCIATION STUDY; HUMANS; LUNG; LUNG DISEASES; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; YOUNG ADULT;

EID: 84949293492     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms9658     Document Type: Article

References (70)

1. Hole, D. J. et al. Impaired lung function and mortality risk in men and women: findings from the Renfrew and Paisley prospective population study. BMJ 313, 711-715 discussion 715-716 (1996).
2. Young, R. P., Hopkins, R. & Eaton, T. E. Forced expiratory volume in one second: not just a lung function test but a marker of premature death from all causes. Eur. Respir. J. 30, 616-622 (2007).
3. Lopez, A. D. et al. Chronic obstructive pulmonary disease: current burden and future projections. Eur. Respir. J. 27, 397-412 (2006).
4. Lozano, R. et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380, 2095-2128 (2012).
5. Zappala, C. J. et al. Marginal decline in forced vital capacity is associated with a poor outcome in idiopathic pulmonary fibrosis. Eur. Respir. J. 35, 830-836 (2010).
6. Abbey, D. E. et al. Long-term particulate and other air pollutants and lung function in nonsmokers. Am. J. Respir. Crit. Care Med. 158, 289-298 (1998).
7. Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis Management and Prevention of COPD. http://www.goldcopd.org/ (2014).
8. Wilk, J. B. et al. Evidence for major genes influencing pulmonary function in the NHLBI family heart study. Genet. Epidemiol. 19, 81-94 (2000).
9. Palmer, L. J. et al. Familial aggregation and heritability of adult lung function: results from the Busselton Health Study. Eur. Respir. J. 17, 696-702 (2001).
10. Hancock, D. B. et al. Meta-analyses of genome-wide association studies identify multiple loci associated with pulmonary function. Nat. Genet. 42, 45-52 (2010).
11. Loth, D. W. et al. Genome-wide association analysis identifies six new loci associated with forced vital capacity. Nat. Genet. 46, 669-677 (2014).
12. Repapi, E. et al. Genome-wide association study identifies five loci associated with lung function. Nat. Genet. 42, 36-44 (2010).
13. Soler Artigas, M. et al. Genome-wide association and large-scale follow up identifies 16 new loci influencing lung function. Nat. Genet. 43, 1082-1090 (2011).
14. Wilk, J. B. et al. A genome-wide association study of pulmonary function measures in the Framingham Heart Study. PLoS Genet. 5, e1000429 (2009).
15. Maher, B. Personal genomes: the case of the missing heritability. Nature 456, 18-21 (2008).
16. Manolio, T. A. et al. Finding the missing heritability of complex diseases. Nature 461, 747-753 (2009).
17. Gibson, G. Rare and common variants: twenty arguments. Nat. Rev. Genet. 13, 135-145 (2011).
18. - 1000 Genomes Project Consortium. An integrated map of genetic variation from 1,092 human genomes. Nature 491, 56-65 (2012).
19. Devlin, B. & Roeder, K. Genomic control for association studies. Biometrics 55, 997-1004 (1999).
20. Lamontagne, M. et al. Refining susceptibility loci of chronic obstructive pulmonary disease with lung eqtls. PLoS ONE 8, e70220 (2013).
21. Westra, H. J. et al. Systematic identification of trans eQTLs as putative drivers of known disease associations. Nat. Genet. 45, 1238-1243 (2013).
22. Rosenbloom, K. R. et al. ENCODE data in the UCSC Genome Browser: year 5 update. Nucleic Acids Res. 41, D56-D63 (2013).
23. Uhlen, M. et al. Towards a knowledge-based Human Protein Atlas. Nat. Biotechnol. 28, 1248-1250 (2010).
24. GTEx Consortium. The Genotype-Tissue Expression (GTEx) project. Nat. Genet. 45, 580-585 (2013).
25. Melen, E. et al. Expression analysis of asthma candidate genes during human and murine lung development. Respir. Res. 12, 86 (2011).
26. Waller-Evans, H. et al. The orphan adhesion-GPCR GPR126 is required for embryonic development in the mouse. PLoS ONE 5, e14047 (2010).
27. Moriguchi, T. et al. DREG, a developmentally regulated G protein-coupled receptor containing two conserved proteolytic cleavage sites. Genes Cells 9, 549-560 (2004).
28. Paavola, K. J., Sidik, H., Zuchero, J. B., Eckart, M. & Talbot, W. S. Type IV collagen is an activating ligand for the adhesion G protein-coupled receptor GPR126. Sci. Signal. 7, ra76 (2014).
29. Obeidat, M. e et al. GSTCD and INTS12 regulation and expression in the human lung. PLoS ONE 8, e74630 (2013).
30. Dabovic, B. et al. Function of latent TGFbeta binding protein 4 and fibulin 5 in elastogenesis and lung development. J. Cell. Physiol. 230, 226-236 (2015).
31. Sterner-Kock, A. et al. Disruption of the gene encoding the latent transforming growth factor-beta binding protein 4 (LTBP-4) causes abnormal lung development, cardiomyopathy, and colorectal cancer. Genes Dev. 16, 2264-2273 (2002).
32. Cho, M. H. et al. A genome-wide association study of COPD identifies a susceptibility locus on chromosome 19q13. Hum. Mol. Genet. 21, 947-957 (2012).
33. Thorgeirsson, T. E. et al. Sequence variants at CHRNB3-CHRNA6 and CYP2A6 affect smoking behavior. Nat. Genet. 42, 448-453 (2010).
34. Li, J. et al. The anti-proliferative function of the TGF-beta1 signalling pathway involves the repression of the oncogenic TBX2 by its homologue TBX3. J. Biol. Chem. 289, 35633-35643 (2014).
35. Follit, J. A. et al. The Golgin GMAP210/TRIP11 anchors IFT20 to the Golgi complex. PLoS Genet. 4, e1000315 (2008).
36. Kawaguchi, Y. et al. CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1. Nat. Genet. 8, 221-228 (1994).
37. Brandsma, C. A. et al. A large lung gene expression study identifying fibulin-5 as a novel player in tissue repair in COPD. Thorax 70, 21-32 (2015).
38. Cho, M. H. et al. Risk loci for chronic obstructive pulmonary disease: a genomewide association study and meta-analysis. Lancet. Respir. Med. 2, 214-225 (2014).
39. Groenman, F., Rutter, M., Caniggia, I., Tibboel, D. & Post, M. Hypoxiainducible factors in the first trimester human lung. J. Histochem. Cytochem. 55, 355-363 (2007).
40. Ovrevik, J. et al. AhR and Arnt differentially regulate NF-kappaB signaling and chemokine responses in human bronchial epithelial cells. Cell Commun. Signal. 12, 48 (2014).
41. Petrache, I. et al. Ceramide synthases expression and role of ceramide synthase-2 in the lung: insight from human lung cells and mouse models. PLoS ONE 8, e62968 (2013).
42. Boyd, A. et al. Cohort Profile: the 'children of the 90s'-the index offspring of the Avon Longitudinal Study of Parents and Children. Int. J. Epidemiol. 42, 111-127 (2013).
43. Welter, D. et al. The NHGRI GWAS Catalog, a curated resource of SNP-trait associations. Nucleic Acids Research 42, D1001-D1006 (2014).
44. Lango Allen, H. et al. Hundreds of variants clustered in genomic loci and biological pathways affect human height. Nature 467, 832-838 (2010).
45. Lettre, G. et al. Identification of ten loci associated with height highlights new biological pathways in human growth. Nat. Genet. 40, 584-591 (2008).
46. Berndt, S. I. et al. Genome-wide meta-analysis identifies 11 new loci for anthropometric traits and provides insights into genetic architecture. Nat. Genet. 45, 501-512 (2013).
47. Albagha, O. M. et al. Genome-wide association identifies three new susceptibility loci for Paget's disease of bone. Nat. Genet. 43, 685-689 (2011).
48. Kemp, J. P. et al. Phenotypic dissection of bone mineral density reveals skeletal site specificity and facilitates the identification of novel loci in the genetic regulation of bone mass attainment. PLoS Genet. 10, e1004423 (2014).
49. Pei, Y. F. et al. Meta-analysis of genome-wide association data identifies novel susceptibility loci for obesity. Hum. Mol. Genet. 23, 820-830 (2014).
50. Macgregor, S. et al. Genome-wide association study identifies a new melanoma susceptibility locus at 1q21.3. Nat. Genet. 43, 1114-1118 (2011).
51. Porcu, E. et al. A meta-analysis of thyroid-related traits reveals novel loci and gender-specific differences in the regulation of thyroid function. PLoS Genet. 9, e1003266 (2013).
52. Segrè, A. V. et al. Common inherited variation in mitochondrial genes is not enriched for associations with type 2 diabetes or related glycemic traits. PLoS Genet. 6, e1001058 (2010).
53. Wood, A. R. et al. Defining the role of common variation in the genomic and biological architecture of adult human height. Nat. Genet. 46, 1173-1186 (2014).
54. Tada, H. et al. Multiple associated variants increase the heritability explained for plasma lipids and coronary artery disease. circulation. Cardiovasc. Genet. 7, 583-587 (2014).
55. Wain, L. V. et al. Novel insights into the genetics of smoking behaviour, lung function, and chronic obstructive pulmonary disease (UK BiLEVE): a genetic association study in UK Biobank. Lancet Respir. Med. doi: 10.1016/S2213-2600(15)00283-0 (2015).
56. Soler Artigas, M. et al. Effect of five genetic variants associated with lung function on the risk of chronic obstructive lung disease, and their joint effects on lung function. Am. J. Respir. Crit. Care Med. 184, 786-795 (2011).
57. Castaldi, P. J. et al. The association of genome-wide significant spirometric loci with chronic obstructive pulmonary disease susceptibility. Am. J. Respir. Cell Mol. Biol. 45, 1147-1153 (2011).
58. Pillai, S. G. et al. A genome-wide association study in chronic obstructive pulmonary disease (COPD): identification of two major susceptibility loci. PLoS Genet. 5, e1000421 (2009).
59. Cho, M. H. et al. Variants in FAM13A are associated with chronic obstructive pulmonary disease. Nat. Genet. 42, 200-202 (2010).
60. Wilk, J. B. et al. Genome-wide association studies identify CHRNA5/3 and HTR4 in the development of airflow obstruction. Am. J. Respir. Crit. Care Med. 186, 622-632 (2012).
61. Li, Y. & Abecasis, G. R. Mach 1.0: rapid haplotype construction and missing genotype inference. Am. J. Hum. Genet. S79, 2290 (2006).
62. Howie, B., Fuchsberger, C., Stephens, M., Marchini, J. & Abecasis, G. R. Fast and accurate genotype imputation in genome-wide association studies through pre-phasing. Nat. Genet. 44, 955-959 (2012).
63. Howie, B. N., Donnelly, P. & Marchini, J. A flexible and accurate genotype imputation method for the next generation of genome-wide association studies. PLoS Genet. 5, e1000529 (2009).
64. Fuchsberger, C., Taliun, D., Pramstaller, P. P., Pattaro, C. & consortium, C. K GWAtoolbox: an R package for fast quality control and handling of genomewide association studies meta-analysis data. Bioinformatics 28, 444-445 (2012).
65. Yang, J. et al. Conditional and joint multiple-SNP analysis of GWAS summary statistics identifies additional variants influencing complex traits. Nat. Genet. 44, S361-S363 (2012).
66. Kumar, P., Henikoff, S. & Ng, P. C. Predicting the effects of coding nonsynonymous variants on protein function using the SIFT algorithm. Nat. Protoc. 4, 1073-1081 (2009).
67. Adzhubei, I. A. et al. A method and server for predicting damaging missense mutations. Nat. Methods 7, 248-249 (2010).
68. Kircher, M. et al. A general framework for estimating the relative pathogenicity of human genetic variants. Nat. Genet. 46, 310-315 (2014).
69. Ritchie, G. R., Dunham, I., Zeggini, E. & Flicek, P. Functional annotation of noncoding sequence variants. Nat. Methods 11, 294-296 (2014).
70. Steiling, K. et al. A dynamic bronchial airway gene expression signature of chronic obstructive pulmonary disease and lung function impairment. Am. Respir. Crit. Care Med. 187, 933-942 (2013).